Lifecore Biomedical (NASDAQ: LFCR) reported Q2 EPS of ($0.25), $0.02 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $32.56 million versus the consensus estimate of $30.18 million.

For earnings history and earnings-related data on Lifecore Biomedical (LFCR) click here.